Benzodiazepine Study for the Treatment of Seizure Clusters in a Third Level Mexican Neurological Center

• Status: Recruiting
• Trial end date: 2023-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The aim of this study is to determine the efficacy in seizure reduction when comparing orodispersable clonazepam versus usual treatment (i.e. medication load, intravenous high- dose benzodiazepines) of seizure clusters in a third level center of care in Mexico city.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez
• Treatments: Clonazepam; Midazolam

Criteria

Inclusion Criteria:

• At least age of 18

• Patient available for follow-up

• Previous diagnosis of epilepsy

• Patient meets criteria for seizure clusters (3 or more seizures in a period of 24 hours)

Exclusion Criteria:

• Risk factors for epilepsy have been identified and uncontrolled.

• Younger than 18 years olf

• Follow- up in another healthcare unit

• No previous epilepsy diagnosis

• Adequate control of epilepsy

• Patient meets criteria for clinical or electrographic status epilepticus.